Assertio Holdings, Inc. Updates First Quarter 2023 Financial Results Call Time to Tuesday, May 9, 2023 at 11:30 am Eastern Time

LAKE FOREST, Ill., May 05, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it will release first quarter 2023 financial results on Tuesday, May 9, 2023, before the market open.

Metadata
Provider: 
GlobeNewswire, Inc.GlobeNewswire, Inc.
Retrieved on: 
Friday, May 5, 2023
Information
Tags: 
Telephone, ASRT, Webcast, Disclosure, Patient, Software, Cryptocurrency, Broadcasting
Geotags: 
LAKE FOREST, IL, US
⚠ partially generated by AI ↴
Organisation: 
ASSERTIO, ASSERTIO HOLDINGS, ASSERTIO HOLDINGS, INC.
Summary
Key Points: 
  • LAKE FOREST, Ill., May 05, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it will release first quarter 2023 financial results on Tuesday, May 9, 2023, before the market open.
  • Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 11:30 a.m. Eastern Time.
  • Please connect at least 10 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast.
  • A webcast replay of the call will be available approximately two hours after the call on Assertio’s investor website.



LAKE FOREST, Ill., May 05, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that it will release first quarter 2023 financial results on Tuesday, May 9, 2023, before the market open. Following the release of its financial results, Assertio’s management will host a live webcast of the earnings conference call at 11:30 a.m. Eastern Time. The schedule change is in order to ensure compliance with SEC disclosure requirements in light of the pending transaction with Spectrum Pharmaceuticals, Inc.

To access the live webcast, conference call information, and other materials, please visit Assertio’s investor relations website at http://investor.assertiotx.com/overview/default.aspx. Please connect at least 10 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. For those wishing to join by telephone only, please dial +1-929-201-5912.

A webcast replay of the call will be available approximately two hours after the call on Assertio’s investor website.

About Assertio
Assertio is a specialty pharmaceutical company offering differentiated products to patients utilizing a non-personal promotional model. We have built and continue to build our commercial portfolio by identifying new opportunities within our existing products as well as acquisitions or licensing of additional approved products. To learn more about Assertio, visit www.assertiotx.com.

Investor Contact
Matt Kreps
Darrow Associates Investor Relations
+1-214-597-8200
[email protected]


Primary Logo
Copyright: 
2023 GlobeNewswire, Inc.. All Rights Reserved.